News
The "Drug Discovery Services Market by Process (Target Validation, Hit-to-Lead, Lead Optimization), Type (Chemistry, Biology), Therapeutic Area (Oncology, Neurology, Infectious, CVD), Drug Type (Small ...
Researchers have discovered a type of "molecular glue" that can be used to inhibit certain pathological protein interactions.
COMSTECH, the Ministerial Standing Committee on Scientific and Technological Cooperation of the OIC, in collaboration with ...
3d
News-Medical.Net on MSNNuclera expands eProtein Discovery capabilities to enable membrane protein productionNuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ system, today announced the addition of a new membrane protein workflow to ...
head of computational drug discovery at the pharma company AbbVie in Chicago, Illinois, and part of the effort, called the AI Structural Biology Consortium. The consortium’s model will be based ...
Google DeepMind has released TxGemma, a new suite of open-source language models built to support therapeutic development. The models are intended to improve tasks such as drug candidate assessment, ...
The gallbladder plays an important role in digestion but hasn’t received much attention in medical research. However, that’s starting to change. With advances in stem cell technology, scientists can ...
The development and spread of antibiotic resistance represents one of the greatest threats to global health. To overcome ...
A novel artificial intelligence (AI) tool has revealed how disease-linked proteins misfold into harmful structures, a key ...
New center will use cutting-edge AI to accelerate the creation of life-saving medicines AI Small Molecule Drug Discovery Center Photo 1 Left to Right: Ethan Grimes, BS, and Paul Morgan, MD, conduct ...
Oncodesign Services has appointed Dr. Aidan Synnott as chief executive officer, to help strengthen its position as a trusted partner in drug discovery. The appointment reflects the company’s ...
Oncodesign Services, a contract research organization specializing in drug discovery and preclinical development, appointed Dr. Aidan Synnott as chief executive officer, to help strengthen its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results